SIG
CTSO icon

Sargent Investment Group’s Cytosorbents Corp CTSO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$673K Sell
746,200
-77,300
-9% -$69.7K 0.09% 134
2025
Q1
$824K Sell
823,500
-425,363
-34% -$425K 0.13% 109
2024
Q4
$1.31M Sell
1,248,863
-377,384
-23% -$396K 0.21% 85
2024
Q3
$2.44M Buy
1,626,247
+192,747
+13% +$289K 0.44% 48
2024
Q2
$1.01M Buy
1,433,500
+67,181
+5% +$47.2K 0.21% 81
2024
Q1
$1.3M Buy
1,366,319
+57,572
+4% +$54.7K 0.28% 68
2023
Q4
$1.45M Buy
1,308,747
+51,699
+4% +$57.4K 0.32% 64
2023
Q3
$2.36M Sell
1,257,048
-32,498
-3% -$61.1K 0.57% 40
2023
Q2
$4.63M Buy
1,289,546
+71,013
+6% +$255K 1.12% 25
2023
Q1
$4.22M Buy
1,218,533
+234,400
+24% +$812K 1.11% 23
2022
Q4
$1.53M Sell
984,133
-124,100
-11% -$192K 0.47% 52
2022
Q3
$2.03M Buy
1,108,233
+130,737
+13% +$239K 0.63% 41
2022
Q2
$2.14M Buy
977,496
+150,116
+18% +$329K 0.66% 37
2022
Q1
$2.64M Buy
827,380
+42,544
+5% +$136K 0.67% 36
2021
Q4
$3.29M Sell
784,836
-179,305
-19% -$751K 0.75% 33
2021
Q3
$7.83M Buy
964,141
+107,826
+13% +$876K 1.9% 14
2021
Q2
$6.47M Buy
856,315
+72,145
+9% +$545K 1.53% 18
2021
Q1
$6.81M Buy
784,170
+110,585
+16% +$960K 1.79% 14
2020
Q4
$5.37M Sell
673,585
-19,153
-3% -$153K 1.7% 15
2020
Q3
$5.52M Sell
692,738
-7,067
-1% -$56.4K 2.01% 15
2020
Q2
$6.98M Buy
699,805
+228,050
+48% +$2.27M 2.62% 13
2020
Q1
$3.65M Buy
471,755
+204,750
+77% +$1.58M 1.68% 19
2019
Q4
$1.03M Sell
267,005
-28,910
-10% -$111K 0.38% 53
2019
Q3
$1.49M Sell
295,915
-37,995
-11% -$191K 0.67% 37
2019
Q2
$2.21M Buy
333,910
+45,840
+16% +$303K 1.01% 23
2019
Q1
$2.18M Buy
288,070
+38,640
+15% +$293K 1.05% 25
2018
Q4
$2.02M Buy
+249,430
New +$2.02M 1.24% 22